NUCC-0000323
NUCC-0000323 is a potent superoxide dismutase 1 (SOD1) inhibitor. NUCC-0000323 inhibits SOD1 expression. NUCC-0000323 can be used in research of amyotrophic lateral sclerosis (ALS) [1].
Product Specifications
CAS Number
663212-78-0
UNSPSC
12352005
Hazard Statement
H302-H315-H319
Target
SOD
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/nucc-0000323.html
Purity
99.86
Solubility
DMSO : 125 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
BrC1=CC=C(CSC2=NN=C(N2C)C3=CC=NC=C3)C=C1
Molecular Formula
C15H13BrN4S
Molecular Weight
361.26
Precautions
P264-P270-P280-P302+P352-P305+P351+P338-P330-P362+P364-P501
References & Citations
[1]Teepu S, et, al. Small molecule inhibitors of superoxide dismutase expression. US20150210679A1.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Cytokeratin, HMW (AE-3), CF594 conjugate, 0.1mg/mL
Cytokeratin 8/18 (C-51), CF640R conjugate, 0.1mg/mL
Cytokeratin 4 (KRT4) (KRT4/2804), CF488A conjugate, 0.1mg/mL
TPO (Thyroid Peroxidase) (Thyroid Marker) (TPO/1922), CF555 conjugate, 0.1mg/mL
